The AI-Marketplace

One Platform | Multiple Algorithms | Zero Headaches

“ At Pathomation, we believe the future of pathology is not about simply selling algorithms, but about enabling AI to deliver real-world value.”

— Olivier Poulin - Business Development Manager | Pathomation

AI in pathology has already proven its potential. Performance and generalizability are no longer the biggest barriers. The real challenges today lie in infrastructure, interoperability, reimbursement, lengthy validation processes, and workflow integration. These hurdles slow down both the daily use of AI in clinical routines and the larger-scale preparation for AI’s long-term role:

  • Acting as a true assistant to clinical pathologists,

  • Guiding biomarker-driven therapies,

  • Flagging high-risk cancer cases,

  • Enabling departments to develop and validate their own algorithms.

Despite tremendous progress from AI companies, clinical pathologists still struggle to make AI useful in daily routine.

That’s why we created the AI- Marketplace: to remove blockers, accelerate adoption, and unlock AI’s transformative potential for pathology.

The 5 Cornerstones of Pathomation’s AI-Marketplace

Unlock AI with confidence

Pathomation brings you the full benefits of AI and collaboration through a scalable, robust, and flexible infrastructure. By combining the control, speed, and proximity of on-premises installations with the flexibility, interoperability, and adaptability of the cloud, we make it easy to deploy AI across your workflows.

GDPR complexities are minimized: only pixel data is sent to the AI algorithms in the Marketplace, keeping patient information secure at all times.

  • CURRENTLY AVAILABLE

    MINDPEAK

    CE-IVD certified algorithms including:

    "0-click" Breast algorithm ER | PR | HER2 | Ki67 | p53

    “0-click” PD-L1 scoring across multiple tissue types (lung, bladder, gastric, breast, esophagus)

    ROI Breast algorithm ER | PR | HER2 | Ki67 | p53

    ROI PD-L1 across multiple tissue types (lung, bladder, gastric, breast, esophagus)

    AIOSYN

    AiosynQC – Slide quality control

    Aiosyn Mitosis Breast – IVDR-certified algorithm for mitosis counting

  • COMING SOON

    DiaDeep

    Breast Cancer: ER/PR, HER2, Ki-67, D-ISH, Mitosis

    Gastric Cancer: HER2

    Pan-Organ: PD-L1 (CPS / TPS)

    Fraunhofer Institute

    MIKAIA – Image Analysis Multi-tool for Digital Pathology & Spatial Biology (specific algorithms to be defined)

  • YOUR WISHLIST

    Which AI algorithms would you like to see added next?


    We’re building this Marketplace with and for the community, so share your needs and let us know which tools would create the most value for you.